Virtual Reality-training in Theory of Mind in the Childhood Form of Myotonic Dystrophy Type 1
Launched by INSTITUT DE MYOLOGIE, FRANCE · Jun 14, 2023
Trial Information
Current as of September 10, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 6 years and \< 16 years of age
- • Written informed consent
- • Affiliate or beneficiary of a social security scheme
- • Able to comply with all protocol requirements
- • Infantile form of DM1 with molecular confirmation.
- • Development without incident in the first year
- • Normal development in the pre and neonatal period
- • Native language French
- Exclusion Criteria:
- • Unable to participate in the study
- • Inability to comply with protocol requirements
- • Congenital form of DM1
- • IQ\<70 (Intellectual Disability)
About Institut De Myologie, France
The Institut de Myologie, based in France, is a leading research center dedicated to the study of muscle diseases and disorders. Renowned for its multidisciplinary approach, the institute combines cutting-edge scientific research with clinical expertise to advance understanding and treatment of myopathies. With a strong emphasis on innovation, the Institut de Myologie actively sponsors clinical trials aimed at developing new therapeutic strategies and improving patient outcomes. Its collaborative environment fosters partnerships with academic institutions, healthcare providers, and industry stakeholders, positioning it at the forefront of myology research and clinical trials in Europe.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boulogne Billancourt, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported